+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Influenza A Virus, H7N9 Subtype Infections Drug Pipeline Report 2020 - Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

  • ID: 4849262
  • Drug Pipelines
  • October 2019
  • Region: Global
  • 60 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • AusBio Ltd
  • EpiVax
  • Greffex Inc
  • Moderna Therapeutics Inc
  • Ology Bioservices Inc
  • Shionogi & Co Ltd
  • MORE
Influenza A Virus, H7N9 Subtype Infections Drug pipeline report- 2020 is an annual R&D review of Influenza A Virus, H7N9 Subtype Infections pipeline candidates. The report presents the current status of all major Influenza A Virus, H7N9 Subtype Infections therapeutic compounds. Detailed insights into Influenza A Virus, H7N9 Subtype Infections pipeline development, current status, companies, drug profiles and Influenza A Virus, H7N9 Subtype Infections preclinical and clinical trials are included.

2020 Influenza A Virus, H7N9 Subtype Infections Pipeline Market Insights
Influenza A Virus, H7N9 Subtype Infections disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Influenza A Virus, H7N9 Subtype Infections therapies, pipeline by phase and others are included.

Influenza A Virus, H7N9 Subtype Infections Pipeline Drug Profiles
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Influenza A Virus, H7N9 Subtype Infections Therapeutic Drug Candidates
Both active and inactive Influenza A Virus, H7N9 Subtype Infections pipeline drug candidates are included in the report

Influenza A Virus, H7N9 Subtype Infections Clinical Trials and Preclinical Studies
Influenza A Virus, H7N9 Subtype Infections In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Influenza A Virus, H7N9 Subtype Infections Pipeline Market Developments
Influenza A Virus, H7N9 Subtype Infections Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Influenza A Virus, H7N9 Subtype Infections Pipeline Companies in Active Development
The report analyzes Influenza A Virus, H7N9 Subtype Infections pipeline of the below companies-
AusBio Ltd, Cocrystal Pharma Inc, EpiVax, Genentech Inc, Greffex Inc, Hualan Biological Bacterin Co Ltd, Medicago Inc, Medigen Vaccine Biologics Corp, Moderna Therapeutics Inc, NanoViricides Inc, Ology Bioservices Inc, Protein Sciences Corporation, sanofi pasteur, Shionogi & Co Ltd, VirionHealth Ltd, Visterra Inc, Vivaldi Biosciences Inc

Report Coverage
- What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included
- Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others
- Companies
17 Companies investing in Influenza A Virus, H7N9 Subtype Infections pipeline from discovery stage to pre-registration phase are included
- Drug profiles
Over 10 details of each Influenza A Virus, H7N9 Subtype Infections pipeline candidate are included
- Company Profiles
Business overview and contact details of all companies operating in the industry are provided
- Market Developments
News, Developments and other recent industry developments are included
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AusBio Ltd
  • EpiVax
  • Greffex Inc
  • Moderna Therapeutics Inc
  • Ology Bioservices Inc
  • Shionogi & Co Ltd
  • MORE
1. Influenza A Virus, H7N9 Subtype Infections Pipeline Market Insights, 2020
1.1 Influenza A Virus, H7N9 Subtype Infections Disease Overview
1.2 Influenza A Virus, H7N9 Subtype Infections Drug Pipeline Snapshot, 2020
1.2.1 Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs by Phase
1.2.2 Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs by Company
1.2.3 Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs by Mechanism of Action
1.2.4 Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs by Route of Administration

2. Influenza A Virus, H7N9 Subtype Infections Company wise Pipeline Details
AusBio Ltd Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs
  • Company Profile
  • Drug Candidate Details
Cocrystal Pharma Inc Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs
  • Company Profile
  • Drug Candidate Details
EpiVax Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs
  • Company Profile
  • Drug Candidate Details
Genentech Inc Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs
  • Company Profile
  • Drug Candidate Details
Greffex Inc Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs
  • Company Profile
  • Drug Candidate Details
Hualan Biological Bacterin Co Ltd Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs
  • Company Profile
  • Drug Candidate Details
Medicago Inc Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs
  • Company Profile
  • Drug Candidate Details
Medigen Vaccine Biologics Corp Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs
  • Company Profile
  • Drug Candidate Details
Moderna Therapeutics Inc Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs
  • Company Profile
  • Drug Candidate Details
NanoViricides Inc Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs
  • Company Profile
  • Drug Candidate Details
Ology Bioservices Inc Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs
  • Company Profile
  • Drug Candidate Details
Protein Sciences Corporation Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs
  • Company Profile
  • Drug Candidate Details
sanofi pasteur Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs
  • Company Profile
  • Drug Candidate Details
Shionogi & Co Ltd Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs
  • Company Profile
  • Drug Candidate Details
VirionHealth Ltd Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs
  • Company Profile
  • Drug Candidate Details
Visterra Inc Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs
  • Company Profile
  • Drug Candidate Details
Vivaldi Biosciences Inc Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs
  • Company Profile
  • Drug Candidate Details
3. Influenza A Virus, H7N9 Subtype Infections Drug Pipeline Profiles
3.1 Discovery and Preclinical Drug Profiles
3.2 Phase 1 Drug Profiles
3.3 Phase 2 Drug Profiles
3.4 Phase 3 Drug Profiles

4. Influenza A Virus, H7N9 Subtype Infections Pipeline News and Developments

5. Appendix
5.1 Primary and Secondary Research Methodology
5.2 Publisher Expertize
5.3 Contacts
Note: Product cover images may vary from those shown
3 of 3
  • AusBio Ltd
  • Cocrystal Pharma Inc
  • EpiVax
  • Genentech Inc
  • Greffex Inc
  • Hualan Biological Bacterin Co Ltd
  • Medicago Inc
  • Medigen Vaccine Biologics Corp
  • Moderna Therapeutics Inc
  • NanoViricides Inc
  • Ology Bioservices Inc
  • Protein Sciences Corporation
  • sanofi pasteur
  • Shionogi & Co Ltd
  • VirionHealth Ltd
  • Visterra Inc
  • Vivaldi Biosciences Inc
Note: Product cover images may vary from those shown
Adroll
adroll